Because cannabis products can stimulate activity of the ECS, they're obvious targets for potential treatments, and a ton of research is going on around the world. We also have medications made from synthetic (lab-created) cannabinoids, such as the drug nabilone.
These conditions are sometimes called "functional conditions" or "central sensitivity syndromes." They tend to be resistant to most treatments, so researchers are looking into cannabis-based treatments.
The Role of Receptors and Enzymes
Certainly, cannabinoids such as marijuana and CBD oil appear to hold a lot of promise as treatments for a wide range of ailments. However, keep in mind that any treatment—even natural ones—can cause unwanted side effects. Self-treatment can be dangerous at put your health at risk, so be sure to include your healthcare provider in your decisions.
CBD already is in use for pediatric epilepsy, pain, inflammation, acne, asthma, and a host of other conditions.
As medical science has learned more about the ECS, it's also discovered several conditions that appear to be related to dysregulation of the system, which is called clinical endocannabinoid deficiency (CECD). CECD isn't a disease itself but is an umbrella term encompassing conditions with this common feature.
Cannabidiol (CBD) is a chemical in the Cannabis sativa plant, also known as cannabis or hemp. One specific form of CBD is approved as a drug in the U.S. for seizure.
How effective is it?
Children: It is possibly safe for children to take a specific prescription CBD product (Epidiolex) by mouth in doses up to 25 mg/kg daily. This product is approved for use in children with certain conditions who are at least 1 year old. It isn’t clear if other CBD products are safe in children.
Are there interactions with herbs and supplements?
CBD has most often been used by adults in doses of 200 mg or less per day. Speak with a healthcare provider to find out what dose might be best for a specific condition.